TXMD News and Press, TherapeuticsMD Inc. From 08/06/20

- 2Q20 total net product revenue of $10.7 million resilient despite COVID-19 pandemic - - ANNOVERA® prescriptions increased approximately 100% for the eight weeks ended July 24, 2020 over the previous eight week period- - IMVEXXY® new prescriptions increased 33% for the eight...

-Executive Management to Host Conference Call on August 6, 2020 at 8:30 a.m. ET- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that it will report its second quarter 2020 financial results on Thursday, August 6, 2020, before the ope...

Penny Stocks To Watch Before August The next few weeks are big for earnings. While some are literally betting on options strategies, other traders are focusing on a different type of low priced investment “option”. I’m talking about penny stocks . There’s likely to...

China Finance Online (NASDAQ: JRJC ) +148%  on agreement with Dow Jones. More news on: China Finance Online Co. Limited, Capitala Finance Corp, Immutep Limited, Stocks on the move, , Read more ...

TherapeuticsMD (NASDAQ: TXMD ) to expand  access to Annovera (segesterone acetate and ethinyl estradiol vaginal system), an annual birth control ring via the Nurx virtual clinic for women’s health. More news on: TherapeuticsMD, Inc., Healthcare stocks news, Rea...

Largest online practice for women’s health now offers the first FDA-approved long-lasting birth control method that does not require a medical procedure TherapeuticsMD, an innovative women’s healthcare company, and Nurx, the largest online practice for women’s heal...

Many generic drug makers began the year with a strong start after a dismal performance in 2019. The recent market plunge from the COVID-19 pandemic caused many pharmaceutical stocks to lose decent portions of their market values. Despite a broad market recovery, some of these stocks are stil...

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, announced today the appointment of James C. D’Arecca as the Company’s Chief Financial Officer, effective June 1, 2020. Mr. D’Arecca succeeds Daniel A. Cartwright, who has retired from hi...

With earnings season in the rear-view mirror for the specialty pharmaceutical sector, J.P. Morgan is updating its positioning on the sector as the COVID-19 pandemic marches on - reiterating its favorites in the area and issuing downgrades to a couple of companies facing challenges. More ne...

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that the company will participate in the BofA Securities 2020 Health Care Conference being held virtually. Chief Executive Officer Robert G. Finizio will provide an overview of the company at...